This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
Incorporation and positional variation of an N-methyl moiety within cyclic peptides significantly alters their conformation, which in turn unpredictably affects cytotoxicity and binding affinity for the oncogenic regulator Hsp90.
Why it matters
Understanding how small chemical modifications like N-methylation affect peptide conformation and activity can guide the design of more effective peptide-based therapeutics targeting protein-protein interactions.
How the study worked
Seven cyclic peptides with varied N-methyl group positions were synthesized and tested for biological activity, including cytotoxicity and Hsp90 binding affinity, to assess how N-methyl placement influences function.
What this study cannot tell us
The study does not specify the detailed biological models or sample sizes used, and the unpredictable nature of conformational changes may complicate rational drug design.
Read the original research
Hitting a Moving Target: How Does an N-Methyl Group Impact Biological Activity?
ChemMedChem, 11(8), 881-92
Citation
Koay, Yen Chin; Richardson, Nicole L; Zaiter, Samantha S; Kho, Jessica; Nguyen, Sheena Y; Tran, Daniel H; Lee, Ka Wai; Buckton, Laura K; McAlpine, Shelli R. (2016). Hitting a Moving Target: How Does an N-Methyl Group Impact Biological Activity?. ChemMedChem, 11(8), 881-92. https://doi.org/10.1002/cmdc.201500572